Patients may be exposed to hormone-disrupting chemicals in medications, medical supplies

medication
Credit: CC0 Public Domain

Health care providers may unintentionally expose patients to endocrine-disrupting chemicals (EDCs) by prescribing certain medications and using medical supplies, according to a perspective published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

Exposure to EDCs, chemicals that disrupt the body's natural hormones, is most often associated with industrial pollution, contaminated food and water, or personal and home care products. Less appreciated is the fact that some medications and medical devices also contain these harmful chemicals. This includes both prescribed and over-the-counter medications as well as used in the hospital, including among the most vulnerable patients in the neonatal intensive care unit. Unfortunately, most are unaware of these risks, and patients are unaware of their exposure.

"Through the prescribing of medications and the use of , health care providers expose patients to chemicals that can disrupt the body's natural hormones," said the study's lead author, Robert Michael Sargis, M.D., Ph.D., of the University of Illinois at Chicago in Chicago, Ill. "In order to provide ethically sound medical care, the health care community must be made aware of these risks, manufacturers must strive to identify and eliminate endocrine-disrupting chemicals from their products, and patients must be empowered with knowledge and options to make informed decisions that limit their exposure to potentially harmful chemicals. As clinicians, we have an ethical imperative to act on this issue to protect our patients."

The authors are calling on physicians to become educated about their role in exposing patients to these chemicals. They express the need for better patient education and a commitment on the part of physicians to live up to their ethical mandates to discuss the risks of EDC exposure. Regulatory agencies and manufacturers also need to identify and eliminate EDCs in medications and and develop safer alternatives.

"As , we need to do a better job of limiting the threats of chemical exposures to our patients' health by ending our complicity in mediating those exposures," Sargis said.


Explore further

Disparities in exposure to toxins may drive higher diabetes rates in minorities

More information: Matthew Genco et al. Unwitting Accomplices: Endocrine Disruptors Confounding Clinical Care, The Journal of Clinical Endocrinology & Metabolism (2020). DOI: 10.1210/clinem/dgaa358
Citation: Patients may be exposed to hormone-disrupting chemicals in medications, medical supplies (2020, July 2) retrieved 13 August 2020 from https://medicalxpress.com/news/2020-07-patients-exposed-hormone-disrupting-chemicals-medications.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments